HER-2 expression is correlated with multimodal imaging features in breast cancer: a pilot study
Xiao-Dan Zhang, Min Kou, Wei-Yan Zou, Xu Duan, Gui-Xin Di, Wei Qin, Li-Hui Bian, Ze-Peng Ma · 2024
Read HER-2 expression is correlated with multimodal imaging features in breast cancer: a pilot study by Xiao-Dan Zhang, Min Kou, Wei-Yan Zou, Xu Duan, Gui-Xin Di, Wei Qin, Li-Hui Bian, Ze-Peng Ma (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11613333.txt.
Description
Xiao-Dan Zhang and co-authors ask whether scans can hint at a key breast cancer marker in a 2024 pilot study. The marker, HER-2, helps guide treatment choice. It is usually found by testing tumor tissue, not by looking at images.
The team studied 62 patients who had ultrasound, mammography, and MRI scans within a month before surgery or biopsy. Two scan traits differed between marker-positive and marker-negative groups. A bright halo around the lump on ultrasound was one, and a water movement value on MRI was the other. Each trait alone predicted the marker only modestly. The authors say combining scan traits with tissue tests may help judge prognosis.
Catalog record
| CREATOR | Xiao-Dan Zhang, Min Kou, Wei-Yan Zou, Xu Duan, Gui-Xin Di, Wei Qin, Li-Hui Bian, Ze-Peng Ma |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |